Form 4 for IMA ImageneBio, Inc.
Accepted 2025-07-29 00:00:00 ET · period of report 2025-07-25 · accession 0000950170-25-099848 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-29 | 2025-07-28 | IMA | Marango Jotin | CFO | F - Tax | $17.16 | -4,630 | 11.1K | -29% | -$79.5K |
| D | 2025-07-29 | 2025-07-28 | IMA | Marango Jotin | CFO | A - Grant | — | +15.8K | 15.8K | New | — |
| DM | 2025-07-29 | 2025-07-25 | IMA | Marango Jotin | CFO | D - Sale to Iss | $0.00 | -683.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-28 | F | D | 4,630 | $17.16 | 11,146 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-28 | A | A | 15,776 | — | 15,776 | D | — | — | (F1) In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. ("Ikena")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-07-25 | D | D | 397,199 | $0.00 | 0 | D | — · — to — | 397,199 Common Stock | (F1) In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. ("Ikena")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-07-25 | D | D | 105,000 | $0.00 | 0 | D | — · — to — | 105,000 Common Stock | (F1) In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. ("Ikena")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-07-25 | D | D | 181,000 | $0.00 | 0 | D | — · — to — | 181,000 Common Stock | (F1) In connection of the closing of the Merger between the Company (formerly known as Ikena Oncology, Inc. ("Ikena")) and Inmagene Biopharmaceuticals, shares of the combined company were issued on July 28 in exchange for certain options held by the holder in Ikena. |